DE69739001D1 - T zell antigen rezeptor peptide - Google Patents

T zell antigen rezeptor peptide

Info

Publication number
DE69739001D1
DE69739001D1 DE69739001T DE69739001T DE69739001D1 DE 69739001 D1 DE69739001 D1 DE 69739001D1 DE 69739001 T DE69739001 T DE 69739001T DE 69739001 T DE69739001 T DE 69739001T DE 69739001 D1 DE69739001 D1 DE 69739001D1
Authority
DE
Germany
Prior art keywords
peptides
cell antigen
peptide sequence
amino acids
antigen receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739001T
Other languages
English (en)
Inventor
Nicholas Manolios
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Sydney and Central Coast Area Health Services
Original Assignee
Northern Sydney and Central Coast Area Health Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO0393A external-priority patent/AUPO039396A0/en
Priority claimed from AUPO0389A external-priority patent/AUPO038996A0/en
Priority claimed from AUPO0390A external-priority patent/AUPO039096A0/en
Priority claimed from AUPO0392A external-priority patent/AUPO039296A0/en
Priority claimed from AUPO0391A external-priority patent/AUPO039196A0/en
Priority claimed from AUPO0394A external-priority patent/AUPO039496A0/en
Application filed by Northern Sydney and Central Coast Area Health Services filed Critical Northern Sydney and Central Coast Area Health Services
Application granted granted Critical
Publication of DE69739001D1 publication Critical patent/DE69739001D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69739001T 1996-06-11 1997-06-11 T zell antigen rezeptor peptide Expired - Lifetime DE69739001D1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPO0393A AUPO039396A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory cd3-epsilon chain peptides
AUPO0389A AUPO038996A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory TCR-alpha chain peptides
AUPO0390A AUPO039096A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory t-cell antigen receptor clonotypic inter-chain disulphide peptides
AUPO0392A AUPO039296A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory cd3-gamma chain peptides
AUPO0391A AUPO039196A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory t-cell antigen receptor alpha chain peptides
AUPO0394A AUPO039496A0 (en) 1996-06-11 1996-06-11 Novel immunomodulatory cd3-delta chain peptides
PCT/AU1997/000367 WO1997047644A1 (en) 1996-06-11 1997-06-11 T cell antigen receptor peptides

Publications (1)

Publication Number Publication Date
DE69739001D1 true DE69739001D1 (de) 2008-10-30

Family

ID=27542959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69739001T Expired - Lifetime DE69739001D1 (de) 1996-06-11 1997-06-11 T zell antigen rezeptor peptide

Country Status (9)

Country Link
US (1) US7192928B1 (de)
EP (2) EP0960119B1 (de)
JP (3) JP4156671B2 (de)
AT (1) ATE408617T1 (de)
AU (1) AU739130B2 (de)
CA (1) CA2257973C (de)
DE (1) DE69739001D1 (de)
ES (1) ES2314982T3 (de)
WO (1) WO1997047644A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070478A1 (en) * 1996-06-11 2005-03-31 Northern Sydney Area Health Services T cell antigen receptor peptides
US7026294B2 (en) * 2000-05-19 2006-04-11 University Of Maryland Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
WO2005115430A1 (en) * 2004-05-27 2005-12-08 Gropep Limited Treatment of inflammatory airway disease
US10138276B2 (en) 2009-09-30 2018-11-27 Signablok, Inc. Inhibition of TCR signaling with peptide variants
US10238741B2 (en) 2014-10-10 2019-03-26 The Trustees Of Columbia University In The City Of New York Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof
WO2020036987A1 (en) 2018-08-13 2020-02-20 Signablok, Inc. Peptides and compositions for targeted treatment and imaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
WO1991009613A1 (en) * 1989-12-22 1991-07-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Synthetic peptides as modulators of functional responses of intact cells
US5200397A (en) 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
US20020098197A1 (en) * 1994-07-21 2002-07-25 Alesandro Sette Hla binding peptides and their uses
ATE466869T1 (de) * 1993-03-05 2010-05-15 Epimmune Inc Verfahren zur herstellung von immunogenen hla- a2.1-bindenden peptiden
ES2318848T3 (es) 1993-09-14 2009-05-01 Pharmexa Inc. Peptidos que se unen a pan dr para potenciar la respuesta inmunitaria.
US5936065A (en) * 1993-12-06 1999-08-10 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
CA2186873A1 (en) * 1994-04-01 1995-10-12 Charles J. Hackett Haptenated peptides and uses thereof
US6100377A (en) * 1994-06-10 2000-08-08 The Trustees Of The University Of Pennsylvania Constrained peptides
ES2168456T3 (es) * 1995-01-16 2002-06-16 North Sydney Area Health Serv Peptidos que afectan a los linfocitos t.

Also Published As

Publication number Publication date
EP2009018A2 (de) 2008-12-31
JP4452312B2 (ja) 2010-04-21
CA2257973A1 (en) 1997-12-18
JP4156671B2 (ja) 2008-09-24
EP2009018A3 (de) 2009-03-18
EP0960119A1 (de) 1999-12-01
JP2007145853A (ja) 2007-06-14
JP2000512282A (ja) 2000-09-19
ATE408617T1 (de) 2008-10-15
CA2257973C (en) 2010-02-02
ES2314982T3 (es) 2009-03-16
AU739130B2 (en) 2001-10-04
AU3019397A (en) 1998-01-07
US7192928B1 (en) 2007-03-20
JP4294693B2 (ja) 2009-07-15
EP0960119A4 (de) 2005-01-12
EP0960119B1 (de) 2008-09-17
WO1997047644A1 (en) 1997-12-18
JP2009062379A (ja) 2009-03-26

Similar Documents

Publication Publication Date Title
DK0794961T3 (da) LHRH-antagonistpeptider
CA2210812A1 (en) T-cell affecting peptides
DE69431060D1 (de) Klonierte glutaminsäure-decarboxylase
LU90457I2 (fr) Refacto
EP2848627A3 (de) Behandlung von Autoimmunkrankheiten mittels Copolymer 1 und ähnlichen Copolymeren und Peptiden
DK0466174T3 (da) Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)
DE60024092D1 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
ATE408617T1 (de) T zell antigen rezeptor peptide
DK0579363T3 (da) Behandling af tropisk spastisk parese med peptid T
EP0249394A3 (en) Small peptides wich inhibit binding to t-4 receptors and act as immunogens
TR199901831T2 (xx) Kollagen-II'ye �zg� bir T-h�cresi epitopundan olu�an peptitler.
ES2159628T3 (es) Gen de una proteina de union a fk506.
FI943795A (fi) T-4 reseptoreihin sitoutuvaa antigeeniä kohtaan suunnattujen vasta-aineiden kanssa reagoivia peptidejä ja niiden diagnostinen käyttö

Legal Events

Date Code Title Description
8364 No opposition during term of opposition